Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangdong Kangqili Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company established in 1986 and headquartered in Meizhou, Guangdong. Originally founded as the state-owned enterprise Guangdong Kangbao Pharmaceutical, it has since transitioned into a private high-tech enterprise specializing in the research, development, and manufacturing of Traditional Chinese Medicine (TCM) and chemical pharmaceutical products. The company's diverse portfolio includes treatments for respiratory conditions, hematology, and orthopedics, featuring notable products such as Keteling capsules for bronchitis and Batilol tablets for leukopenia. Kangqili operates a large-scale GMP-certified manufacturing base and distributes its over-the-counter and prescription medications across domestic and regional markets in China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guangdong Kangqili Pharmaceutical.